Carol O’Brien
University of Canberra(AU)Technical University of Denmark(DK)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Cancer Genomics and Diagnostics, HER2/EGFR in Cancer Research, Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Identification of common variants associated with human hippocampal and intracranial volumes(2012)653 cited
- → In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models(2009)472 cited
- → De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability(2014)362 cited
- → TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer(2011)312 cited
- → Predictive Biomarkers of Sensitivity to the Phosphatidylinositol 3′ Kinase Inhibitor GDC-0941 in Breast Cancer Preclinical Models(2010)257 cited
- → GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway(2011)227 cited